Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes (MDS)

Explore clinical trials studying Myelodysplastic Syndromes (MDS). Study availability and eligibility vary by location and protocol.

38 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes (MDS) trial results

Completed

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

NCT01736683

Conditions
Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations
  • Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

NCT01613976

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Sendai, Miyagi, Japan
View Trial Details
Completed

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

NCT02333058

Conditions
Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Bone Marrow Diseases, +5 more
Locations
  • St. Anna Children Hospital Vienna, Austria
  • University Hospital Motol, Charles University, Prague Prague, Czechia
  • University Clinic Düsseldorf Düsseldorf, Germany
  • University Clinic Erlangen-Nürnberg Erlangen, Germany
View all 24 locations
View Trial Details
Completed

Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

NCT01355913

Conditions
Bone Marrow Diseases, Chromosmal Aberrations, Cytogenetic Monitoring, +6 more
Locations
  • University Hospital Aachen Aachen, Germany
  • University Hospital Dresden Dresden, Germany
  • University Hospital Düsseldorf Düsseldorf, Germany
  • Onkologikum Frankfurt am Main, Germany
View all 13 locations
View Trial Details
Completed

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

NCT00528983

Conditions
Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +16 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Central Indiana Cancer Centers Indianapolis, Indiana, United States
  • Kansas University Medical Center Westwood, Kansas, United States
View all 18 locations
View Trial Details
Completed

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

NCT02550535

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • AZ St Jan Brugge-Oostende AV Bruges, Belgium
  • UZ Leuven Leuven, Belgium
  • Uniklinikum Dresden Dresden, Germany
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
View Trial Details

Related conditions